Product logins

Find logins to all Clarivate products below.


ENT Devices – Market Insights – Europe (Supplemental)

The European ENT device market will grow marginally over the forecast period, driven primarily by the faster-growing balloon dilation device and nasal packing segments. Slight FESS procedure volume growth and a gradual shift toward resorbable nasal packing will support market revenues; however, most ENT procedure volumes in Europe will only see marginal growth through 2033, as an effect of adoption of alternative treatments, such as antibiotics, instead of surgery, hindering the pace of market expansion.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for ENT devices in Europe from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
ENT Devices – Market Insights – Japan
The Japanese ENT device market is projected to grow at a modest pace over the forecast period, supported by a slight increase in ENT procedure volumes. This growth will be primarily driven by a…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Video and High-Tech Hardware Devices – Market Insights – United States
The US video and high-tech hardware device market will experience modest expansion through 2035. This growth is primarily driven by the increasing adoption of articulated surgical robotic systems…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…